Skip to main content
Top
Published in: Nutrition Journal 1/2018

Open Access 01-12-2018 | Research

Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes

Authors: Adham Mottalib, Veronica Salsberg, Barakatun-Nisak Mohd-Yusof, Wael Mohamed, Padraig Carolan, David M. Pober, Joanna Mitri, Osama Hamdy

Published in: Nutrition Journal | Issue 1/2018

Login to get access

Abstract

Background

Nutrition Therapy (NT) is essential in type 2 diabetes (T2D) management. Standards of care recommend that each patient engages with a nutritionist (RDN) to develop an individualized eating plan. However, it is unclear if it is the most efficient method of NT. This study evaluates the effects of three different methods of NT on HbA1c and cardiovascular disease risk factors in overweight and obese patients with T2D.

Methods

We randomized 108 overweight and obese patients with T2D (46 M/62F; age 60 ± 10 years; HbA1c 8.07 ± 1.05%; weight 101.4 ± 21.1 kg and BMI 35.2 ± 7.7 kg/m2) into three groups. Group A met with RDN to develop an individualized eating plan. Group B met with RDN and followed a structured meal plan. Group C did similar to group B and received weekly phone support by RDN.

Results

After 16 weeks, all three groups had a significant reduction of their energy intake compared to baseline. HbA1c did not change from baseline in group A, but decreased significantly in groups B (− 0.66%, 95% CI -1.03 to − 0.30) and C (− 0.61%, 95% CI -1.0 to − 0.23) (p value for difference among groups over time < 0.001). Groups B and C also had significant reductions in body weight, body fat percentage and waist circumference.

Conclusion

Structured NT alone improves glycemia in comparison to individualized eating plans in overweight and obese patients with T2D. It also reduces other important cardiovascular disease risk factors like body fat percentage and waist circumference.

Trial registration

The trial was retrospectively registered at clinicaltrials.gov(NCT02520050).
Literature
3.
go back to reference Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab. 2011;96:1654–63.CrossRefPubMedPubMedCentral Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab. 2011;96:1654–63.CrossRefPubMedPubMedCentral
5.
go back to reference Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Suppl 1):S120–43.CrossRefPubMed Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Suppl 1):S120–43.CrossRefPubMed
6.
go back to reference ADA. Lifestyle Management. Sec. 4. In: Standards of medical Care in Diabetes—2017. Diabetes care, vol. 40; 2017. p. S33–43. ADA. Lifestyle Management. Sec. 4. In: Standards of medical Care in Diabetes—2017. Diabetes care, vol. 40; 2017. p. S33–43.
7.
go back to reference Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA. Consensus statement by the American Association of Clinical Endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm–2016 executive summary. Endocr Pract. 2016;22:84–113.CrossRefPubMed Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA. Consensus statement by the American Association of Clinical Endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm–2016 executive summary. Endocr Pract. 2016;22:84–113.CrossRefPubMed
8.
go back to reference Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25:608–13.CrossRefPubMed Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25:608–13.CrossRefPubMed
9.
go back to reference Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes. Diabetes Care. 2015;38:140–9.CrossRefPubMed Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes. Diabetes Care. 2015;38:140–9.CrossRefPubMed
10.
go back to reference ADA. Foundations of care and comprehensive medical evaluation. Sec. 3. In: Standards of medical Care in Diabetes—2016. Diabetes care, vol. 39; 2016. p. S23–35. ADA. Foundations of care and comprehensive medical evaluation. Sec. 3. In: Standards of medical Care in Diabetes—2016. Diabetes care, vol. 39; 2016. p. S23–35.
11.
go back to reference Camelon KM, Hadell K, Jamsen PT, Ketonen KJ, Kohtamaki HM, Makimatilla S, Tormala ML, Valve RH. The plate model: a visual method of teaching meal planning. DAIS project group. Diabetes atherosclerosis intervention study. J Am Diet Assoc. 1998;98:1155–8.CrossRefPubMed Camelon KM, Hadell K, Jamsen PT, Ketonen KJ, Kohtamaki HM, Makimatilla S, Tormala ML, Valve RH. The plate model: a visual method of teaching meal planning. DAIS project group. Diabetes atherosclerosis intervention study. J Am Diet Assoc. 1998;98:1155–8.CrossRefPubMed
12.
go back to reference Giusti J, Rizzotto JA. Interpreting the Joslin Diabetes Center and Joslin clinic clinical nutrition guideline for overweight and obese adults with type 2 diabetes. Curr Diab Rep. 2006;6:405–8.CrossRefPubMed Giusti J, Rizzotto JA. Interpreting the Joslin Diabetes Center and Joslin clinic clinical nutrition guideline for overweight and obese adults with type 2 diabetes. Curr Diab Rep. 2006;6:405–8.CrossRefPubMed
13.
go back to reference Yang YJ, Kim MK, Hwang SH, Ahn Y, Shim JE, Kim DH. Relative validities of 3-day food records and the food frequency questionnaire. Nutr Res Pract. 2010;4:142–8.CrossRefPubMedPubMedCentral Yang YJ, Kim MK, Hwang SH, Ahn Y, Shim JE, Kim DH. Relative validities of 3-day food records and the food frequency questionnaire. Nutr Res Pract. 2010;4:142–8.CrossRefPubMedPubMedCentral
14.
go back to reference Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev. 2003;61:397–412.CrossRefPubMed Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev. 2003;61:397–412.CrossRefPubMed
15.
go back to reference Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ. 2012;344:e1369. Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ. 2012;344:e1369.
16.
go back to reference Group LAR. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;2013:145–54. Group LAR. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;2013:145–54.
17.
go back to reference Pronk NP, Remington PL, on behalf of the Community Preventive Services Task F. Combined diet and physical activity promotion programs for prevention of diabetes: community preventive services task force recommendation statement. Ann Intern Med. 2015;163:465–8.CrossRefPubMed Pronk NP, Remington PL, on behalf of the Community Preventive Services Task F. Combined diet and physical activity promotion programs for prevention of diabetes: community preventive services task force recommendation statement. Ann Intern Med. 2015;163:465–8.CrossRefPubMed
18.
go back to reference Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015;115:1447–63.CrossRefPubMed Franz MJ, Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015;115:1447–63.CrossRefPubMed
19.
go back to reference Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S. The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14:737–52.CrossRef Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S. The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14:737–52.CrossRef
20.
go back to reference Raynor HA, Anderson AM, Miller GD, Reeves R, Delahanty LM, Vitolins MZ, Harper P, Mobley C, Konersman K, Mayer-Davis E. Partial meal replacement plan and quality of the diet at 1 year: action for health in diabetes (look AHEAD) trial. J Acad Nutr Diet. 2015;115:731–42.CrossRefPubMedPubMedCentral Raynor HA, Anderson AM, Miller GD, Reeves R, Delahanty LM, Vitolins MZ, Harper P, Mobley C, Konersman K, Mayer-Davis E. Partial meal replacement plan and quality of the diet at 1 year: action for health in diabetes (look AHEAD) trial. J Acad Nutr Diet. 2015;115:731–42.CrossRefPubMedPubMedCentral
21.
go back to reference Mottalib A, Mohd-Yusof B-N, Shehabeldin M, Pober D, Mitri J, Hamdy O. Impact of diabetes-specific nutritional formulas versus oatmeal on postprandial glucose, insulin, GLP-1 and postprandial Lipidemia. Nutrients. 2016;8:443.CrossRefPubMedCentral Mottalib A, Mohd-Yusof B-N, Shehabeldin M, Pober D, Mitri J, Hamdy O. Impact of diabetes-specific nutritional formulas versus oatmeal on postprandial glucose, insulin, GLP-1 and postprandial Lipidemia. Nutrients. 2016;8:443.CrossRefPubMedCentral
22.
go back to reference Van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care. 2003;26:625–30.CrossRefPubMed Van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care. 2003;26:625–30.CrossRefPubMed
23.
go back to reference Nuttall FQ, Mooradian AD, Gannon MC, Billington C, Krezowski P. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care. 1984;7:465–70.CrossRefPubMed Nuttall FQ, Mooradian AD, Gannon MC, Billington C, Krezowski P. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care. 1984;7:465–70.CrossRefPubMed
24.
go back to reference Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med. 2000;342:1392–8.CrossRefPubMed Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med. 2000;342:1392–8.CrossRefPubMed
25.
go back to reference Hamdy O, Zwiefelhofer D. Weight management using a meal replacement strategy in type 2 diabetes. Curr Diab Rep. 2010;10:159–64.CrossRefPubMed Hamdy O, Zwiefelhofer D. Weight management using a meal replacement strategy in type 2 diabetes. Curr Diab Rep. 2010;10:159–64.CrossRefPubMed
26.
go back to reference Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, Foreyt JP, Hill JO, Trence DL, Vitolins MZ, Look ARG. One-year weight losses in the look AHEAD study: factors associated with success. Obesity (Silver Spring). 2009;17:713–22.CrossRefPubMedCentral Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, Foreyt JP, Hill JO, Trence DL, Vitolins MZ, Look ARG. One-year weight losses in the look AHEAD study: factors associated with success. Obesity (Silver Spring). 2009;17:713–22.CrossRefPubMedCentral
27.
go back to reference Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO, Krakoff J, Otto A, Ryan DH, Vitolins MZ, Look ARG. Four-year weight losses in the look AHEAD study: factors associated with long-term success. Obesity (Silver Spring). 2011;19:1987–98.CrossRefPubMedCentral Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO, Krakoff J, Otto A, Ryan DH, Vitolins MZ, Look ARG. Four-year weight losses in the look AHEAD study: factors associated with long-term success. Obesity (Silver Spring). 2011;19:1987–98.CrossRefPubMedCentral
28.
go back to reference Emadian A, Andrews RC, England CY, Wallace V, Thompson JL. The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups. Br J Nutr. 2015;114:1656–66.CrossRefPubMedPubMedCentral Emadian A, Andrews RC, England CY, Wallace V, Thompson JL. The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups. Br J Nutr. 2015;114:1656–66.CrossRefPubMedPubMedCentral
Metadata
Title
Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
Authors
Adham Mottalib
Veronica Salsberg
Barakatun-Nisak Mohd-Yusof
Wael Mohamed
Padraig Carolan
David M. Pober
Joanna Mitri
Osama Hamdy
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2018
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/s12937-018-0351-0

Other articles of this Issue 1/2018

Nutrition Journal 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.